AUTHORS

Real Money authors - Bruce Kamich

Bruce Kamich

Bruce Kamich is TheStreet's in-house technical analyst with a 43 year career with a number of bulge bracket firms like Morgan Stanley, Smith Barney Harris Upham, and Merrill Lynch. Along the way he accumulated knowledge about the fundamentals of the commodity markets, interest rates, equities and ETFs. 

In addition to writing for theStreet.com Kamich has been teaching technical analysis at Baruch College for the past twenty years.

Kamich was one of the earliest Chartered Market Technicians  or CMTs, a professional designation similar to the CFA title. He has authored two books on charting and technical analysis - "How Technical Analysis Works"  and "Chart Patterns." He is a two-time past president of the Market Technicians Association (now called the CMTA), the professional organization for chartists worldwide. He was also the president of the Market Technicians Association Educational Foundation (MTAEF.org).
Email Bruce Kamich

Recent Articles By The Author

Good Weather, Trusty Charts Are Helping Brunswick Rally

The charts and indicators of BC suggest further gains are possible.

Can Microsoft Continue its Leadership Role in the Stock Market?

Let's check out the charts and indicators to see.

Let's See How an Upgrade 'Align's with Charts and Indicators on ALGN

TheStreet's quantitative service gives a buy recommendation for Align Technologies and it looks like a dip could be an opportunity for investors.

Mining for Opportunities in Oil? Parsley Energy May Pump Higher Later in Year

A near-term dip in PE could be a buying opportunity for future gains.

Snap Has Hammered Out an Impressive Base Pattern

Here's what we see ahead for this heavily traded stock.

Trading in MGM Resorts Has Been a Big Casino Since March

The volume data and the On-Balance-Volume line moves tell you that MGM has become a huge vehicle for short-term traders.

Tesla Shares May Power Down a Bit Near Term

The charts of the electric vehicle maker are showing some weakening in the stock, though a major shake-out isn't likely.

Hot Stocks Come and Sometimes Go - A Look at Nikola

Prices have soared like a cannabis play or a solar play as everyone believes they need to buy the next new thing.

The Charts of Agenus Need More Development

AGEN is a clinical-stage immuno-oncology company.

Has Apple Finally Become Over Ripe?

Another look at Apple shares which just keep trading higher and higher.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight